Moreover, EGR1 upregulation has been linked to enhanced p53 activity and increased intracellular levels of p66, which may accelerate the progression of NAFLD to liver fibrosis (4, 5, 23–26). This evidence concerns the gene TP53 and Hepatic fibrosis.